EU rushes to authorize Remdesivir as U.S. hoards it
BRUSSELS, July 3 (Xinhua) -- The European Commission on Friday rushed to announce it has given the green light to anti-viral drug Remdesivir for treatment of COVID-19, making it the first drug authorized at the European Union (EU) level for the purpose.
EU Commissioner for Health and Food Safety Stella Kyriakides said the EU has expedited the authorization, approving the drug, made by American biopharmaceutical company Gilead Sciences, in an exceptionally short timeframe.
- Read more about EU rushes to authorize Remdesivir as U.S. hoards it
- Log in or register to post comments